Targeting G protein-coupled A2a adenosine receptors to engineer inflammation in vivo

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 4, 2003, Pages 410-414

  Gomez, Gregorio ^a   Sitkovsky, Michail V ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Hypoxia; Immunosuppressive loop; Metabolic switch

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; METHOTREXATE; RECEPTOR SUBTYPE;

BIOENGINEERING; DOWN REGULATION; HUMAN; HYPOXIA; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MULTIPLE SCLEROSIS; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; TISSUE INJURY;

EID: 0037383393     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00177-2     Document Type: Short Survey

References (43)

1. Ohta A., Sitkovsky M. Role of G protein-coupled adenosine receptors in down-regulation of inflammation and protection from tissue damage. Nature. 414(6866):2001;916-920.
2. E. Shacter, S.A. Weitzman, Chronic inflammation and cancer. Oncology (Huntingt) 16(2) (2002) 217-232.
3. McPherson J.A., Barringhaus K.G., Bishop G.G., Sanders J.M., Rieger J.M., Hesselbacher S.E., Gimple L.W., Powers E.R., Macdonald T., Sullivan G., Linden J., Sarembock I.J. Adenosine A2a receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler. Thromb. Vasc. Biol. 21(5):2001;791-796.
4. Pockley A.G. Heat shock proteins, inflammation, and cardiovascular disease. Circulation. 105(8):2002;1012-1017.
5. Shebuski R.J., Kilgore K.S. Role of inflammatory mediators in thrombogenesis. J. Pharmacol. Exp. Ther. 300(3):2002;729-735.
6. Mulvihill N.T., Foley J.B. Inflammation in acute coronary syndromes. Heart. 87(3):2002;201-204.
7. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41:2001;775-787.
8. Van Belle H., Goossens F., Wynants J. Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am. J. Pathol. 252:1987;H886-H893.
9. Winn H.R., Rubio R., Curnish R.R., Berne R.M. Changes in regional cerebral blood flow (rCBF) caused by increase in CSF concentrations of adenosine and 2-chloroadenosine (CHL-ADO). J. Cereb. Blood Flow Metab. 1:1981;401.
10. K.A. Rudolphi, P. Shubert, Adenosine and brain ischemia, in: L. Bellardinelli, A. Pelleg (Eds.), Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Phisiology, Kluwer, Norwell, 1995, pp. 391-397.
11. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:1994;5.
12. Firestein G.S. Anti-inflammatory effects of adenosine kinase inhibitors in acute and chronic inflammation. Drug Dev. Res. 39:1996;371-376.
13. Eigler A., Greten T.F., Sinha B., Haslberger C., Sullivan G.W., Endres S. Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand. J. Immunol. 45:1997;132-139.
14. Sullivan G.W., Linden J. Role of A2a adenosine receptors in inflammation. Drug Dev. Res. 45:1998;103-112.
15. Huang S., Koshiba M., Apasov S., Sitkovsky M. Role of A2a adenosine receptor-mediated signaling in inhibition of T-cell activation and expansion. Blood. 90:1997;1600-1610.
16. Koshiba M., Kojima H., Huang S., Apasov S., Sitkovsky M.V. Memory of extracellular adenosine/A2a purinergic receptor-mediated signalling in murine T-cells. J. Biol. Chem. 272:1997;25881.
17. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53(4):2001;527-5522.
18. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch. Pharmacol. 362:2000;364-374.
19. Libert F., Parmentier M., Lefort A., Dinsart C., Van Sande J., Maenhaut C., Simons M.J., Dumont J.E., Vassart G. Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science. 244(4904):1989;569-572.
20. Olah M.E., Stiles G.L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35:1995;581-606.
21. q in HEK-293 and HMC-1 mast cells. Mol. Pharmacol. 56:1999;705-713.
22. Jockers R., Linder M.E., Hohenegger M., Nanoff C., Bertin B., Strosberg A.D., Marullo S., Freissmuth M. Species difference in the G protein selectivity of the human and bovine A1-adenosine receptor. J. Biol. Chem. 269:1994;32077-32084.
23. Akbar M., Okajima F., Tomura H., Shimegi S., Kondo Y. A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release. Mol. Pharmacol. 45:1994;1036-1042.
24. Freund S., Ungerer M., Lohse M.J. A1 adenosine receptors expressed in CHO-cells couple to adenylyl cyclase and to phospholipase C. Naunyn Schmiedebergs Arch. Pharmacol. 350:1994;49-56.
25. Gerwins P., Fredholm B.B. Activation of adenosine A1 and bradykinin receptors increases protein kinase C and phospholipase D activity in smooth muscle cells. Naunyn Schmiedebergs Arch. Pharmacol. 351:1995;186-193.
26. Palmer T.M., Gettys T.W., Stiles G.L. Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor. J. Biol. Chem. 270:1995;16895-16902.
27. s : analysis of chimeric A1/A2a adenosine receptors. J. Biol. Chem. 272:1997;337-344.
28. Pierce K.D., Furlong T.J., Selbie L.A., Shine J. Molecular cloning and expression of an adenosine receptor from human brain. Biochem. Biophys. Res. Commun. 187:1992;86-93.
29. olf in rat striatum. Mol. Pharmacol. 58(4):2000;771-777.
30. Gao Z., Chen T., Weber M.J., Linden J. A2b adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells: cross-talk between cyclic AMP and protein kinase C pathways. J. Biol. Chem. 274:1999;5972-5980.
31. Gomez G., Apasov S., Sitkovsky M.V. Immunosuppressive effects of extracellular adenosine on immune cells: implications for the pathogenesis of ADA SCID and immunomodulation. Drug Dev. Res. 53:2001;218-224.
32. Parmely M.J., Zhou W.W., Edwards I.C.K., Borcherding D.R., Silverstein R., Morrison D.C. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J. Immunol. 151(1):1993;389-396.
33. Bouma M.G., Stad R.K., Wildenberg F.A.J.M.v.d., Buurman W.A. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:1994;4159-4168.
34. Hasko G., Szabo C., Nemeth Z.H., Kvetan V., Pastores S.M., Vizi E.S. Adenosine receptor agonists differentially regulate IL-10, TNF-α and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157:1996;4634-4640.
35. Hasko G., Nemeth Z.H., Vizi E.S., Salzman A.L., Szabo C. An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-γ production and prevents lethality in endotoxemic mice. Eur. J. Pharmacol. 358:1998;261-268.
36. McWhinney C.D., Dudley M.W., Bowlin T.L., Peet N.P., Schook L., Bradshaw M., De M., Borcherding D.R., Edwards I.C.K. Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-α Eur. J. Pharmacol. 310:1996;209-216.
37. Sajjadi F.G., Takabayashi K., Foster A.C., Domingo R.C., Firestein G.S. Inhibition of TNF-α expression by adenosine. role of A3 adenosine receptors. J. Immunol. 156:1996;3435-3442.
38. Link A.A., Kino T., Worth J.A., McGuire J.L., Crane M.L., Chrousos G.P., Wilder R.L., Elenkov I.J. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J. Immunol. 164:2000;436-442.
39. s protein-coupled A2a adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2a receptor gene-deficient mice. Biochem. J. 354:2001;123-130.
40. Montesinos M.C., Gadangi P., Longaker M., Sung J., Levine J., Nilsen D., Reibman J., Li M., Hiang C.K., Hirschhorn R., Recht P.A., Ostad E., Levin R.I., Cronstein B.N. Wound healing is accelerated by agonists of A2 (G alpha s-linked) receptors. J. Exp. Med. 186(9):1997;1615-1620.
41. Montesinos M.C., Desai A., Chen J.F., Yee H., Schwarzschild M.A., Fink J.S., Cronstein B. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A2a receptors. Am. J. Pathol. 160(6):2002;2009-2018.
42. Montesinos M.C., Yap J.S., Desai A., Posadas I., McCrary C.T., Cronstein B.N. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonist theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis. Arthritis Rheum. 43(3):2000;563-565.
43. Chan E.S., Cronstein B.N. Molecular action of methotrexate in inflammatory disease. Arthritis Res. 4(4):2002;266-273.